inTEST (INTT) Competitors $5.96 -0.26 (-4.18%) Closing price 04:00 PM EasternExtended Trading$5.97 +0.01 (+0.15%) As of 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock INTT vs. AEHR, QTRX, QSI, MASS, FEIM, SEER, RPID, KEQU, ODYS, and NAUTShould you be buying inTEST stock or one of its competitors? The main competitors of inTEST include Aehr Test Systems (AEHR), Quanterix (QTRX), Quantum-Si (QSI), 908 Devices (MASS), Frequency Electronics (FEIM), Seer (SEER), Rapid Micro Biosystems (RPID), Kewaunee Scientific (KEQU), Odysight.Ai (ODYS), and Nautilus Biotechnology (NAUT). These companies are all part of the "measuring and control equipment" industry. inTEST vs. Aehr Test Systems Quanterix Quantum-Si 908 Devices Frequency Electronics Seer Rapid Micro Biosystems Kewaunee Scientific Odysight.Ai Nautilus Biotechnology Aehr Test Systems (NASDAQ:AEHR) and inTEST (NYSE:INTT) are both small-cap computer and technology companies, but which is the superior business? We will compare the two companies based on the strength of their earnings, community ranking, dividends, risk, institutional ownership, valuation, profitability, media sentiment and analyst recommendations. Does the MarketBeat Community prefer AEHR or INTT? Aehr Test Systems received 121 more outperform votes than inTEST when rated by MarketBeat users. Likewise, 58.15% of users gave Aehr Test Systems an outperform vote while only 57.89% of users gave inTEST an outperform vote. CompanyUnderperformOutperformAehr Test SystemsOutperform Votes13258.15% Underperform Votes9541.85% inTESTOutperform Votes1157.89% Underperform Votes842.11% Does the media prefer AEHR or INTT? In the previous week, inTEST had 7 more articles in the media than Aehr Test Systems. MarketBeat recorded 7 mentions for inTEST and 0 mentions for Aehr Test Systems. Aehr Test Systems' average media sentiment score of 1.61 beat inTEST's score of -0.60 indicating that Aehr Test Systems is being referred to more favorably in the media. Company Overall Sentiment Aehr Test Systems Very Positive inTEST Negative Which has better valuation & earnings, AEHR or INTT? Aehr Test Systems has higher earnings, but lower revenue than inTEST. Aehr Test Systems is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAehr Test Systems$61.48M4.22$33.16M$0.7811.17inTEST$130.69M0.56$9.34M$0.2325.91 Do analysts prefer AEHR or INTT? Aehr Test Systems presently has a consensus target price of $25.00, suggesting a potential upside of 187.03%. inTEST has a consensus target price of $16.00, suggesting a potential upside of 168.46%. Given Aehr Test Systems' higher possible upside, equities research analysts clearly believe Aehr Test Systems is more favorable than inTEST.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aehr Test Systems 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00inTEST 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.33 Which has more risk & volatility, AEHR or INTT? Aehr Test Systems has a beta of 2.21, indicating that its share price is 121% more volatile than the S&P 500. Comparatively, inTEST has a beta of 1.7, indicating that its share price is 70% more volatile than the S&P 500. Is AEHR or INTT more profitable? Aehr Test Systems has a net margin of 43.41% compared to inTEST's net margin of 2.33%. Aehr Test Systems' return on equity of 21.09% beat inTEST's return on equity.Company Net Margins Return on Equity Return on Assets Aehr Test Systems43.41% 21.09% 18.08% inTEST 2.33%5.31%3.42% Do institutionals and insiders believe in AEHR or INTT? 69.7% of Aehr Test Systems shares are owned by institutional investors. Comparatively, 63.2% of inTEST shares are owned by institutional investors. 6.2% of Aehr Test Systems shares are owned by insiders. Comparatively, 5.5% of inTEST shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryAehr Test Systems beats inTEST on 13 of the 19 factors compared between the two stocks. Get inTEST News Delivered to You Automatically Sign up to receive the latest news and ratings for INTT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INTT vs. The Competition Export to ExcelMetricinTESTInstruments to measure electricity IndustryComputer SectorNYSE ExchangeMarket Cap$73.74M$3.94B$23.83B$19.21BDividend YieldN/A0.55%2.96%4.00%P/E Ratio25.9120.2342.7833.45Price / Sales0.562.322,007.3429.18Price / Cash5.7517.8734.7717.52Price / Book0.753.156.314.55Net Income$9.34M$135.28M$736.77M$1.02B7 Day Performance-6.14%-0.97%2.71%2.18%1 Month Performance-11.70%1.51%2.95%-2.05%1 Year Performance-45.92%-11.09%52,746.70%5.45% inTEST Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INTTinTEST2.68 of 5 stars$5.96-4.2%$16.00+168.5%-43.0%$73.74M$130.69M25.91320Earnings ReportNews CoverageGap DownAEHRAehr Test Systems3.6221 of 5 stars$8.70-0.7%$25.00+187.4%-28.7%$259.01M$61.48M11.6090Positive NewsQTRXQuanterix2.2143 of 5 stars$5.78-1.7%$18.25+215.7%-65.0%$224.20M$135.44M-5.45460Upcoming EarningsAnalyst DowngradeNews CoverageQSIQuantum-Si2.2908 of 5 stars$1.21-1.6%$3.48+187.2%-35.6%$221.60M$3.06M-1.89150Upcoming EarningsMASS908 Devices1.1294 of 5 stars$5.33-1.5%$5.33+0.1%-5.6%$188.31M$59.63M-3.0160FEIMFrequency Electronics2.0949 of 5 stars$18.61-1.1%N/A+85.2%$180.09M$65.40M22.70200News CoveragePositive NewsSEERSeer1.8206 of 5 stars$1.96-0.5%$3.00+53.1%-3.8%$117.17M$13.95M-1.51160Upcoming EarningsRPIDRapid Micro Biosystems2.074 of 5 stars$2.34+4.0%$8.00+241.9%+141.9%$101.18M$28.05M-2.09200KEQUKewaunee Scientific2.8661 of 5 stars$32.75-4.9%N/A-12.8%$93.50M$220.03M5.19890Short Interest ↓Positive NewsODYSOdysight.Ai1.6173 of 5 stars$5.43-2.2%$10.00+84.2%N/A$88.55M$3.96M-6.3140News CoverageGap UpNAUTNautilus Biotechnology2.7085 of 5 stars$0.68-1.2%$2.42+255.4%-75.4%$85.78MN/A-1.21130Earnings ReportShort Interest ↑High Trading Volume Related Companies and Tools Related Companies AEHR Competitors QTRX Competitors QSI Competitors MASS Competitors FEIM Competitors SEER Competitors RPID Competitors KEQU Competitors ODYS Competitors NAUT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:INTT) was last updated on 5/2/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredTrump Orders 'National Digital Asset Stockpile'Billionaires Rush Into Digital Banking Token Three massive forces are converging right now, creating what c...Crypto 101 Media | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding inTEST Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share inTEST With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.